© 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. During the day, the stock rose to $0.24 and sunk to $0.184 before settling in for the price of $0.19 at the close. The financial results for the third - quarter ending September 30 2020 were today revealed by Reed's Inc. ( Nasdaq: REED), owner of the... BioLineRX Ltd was a big gainer last Friday and looks set to extend those gains today. See what's happening in the market right now with MarketBeat's real-time news feed. At the time of writing, stock’s 50-day Moving Average stood at $0.2051, while the 200-day Moving Average is $0.5014. Investors should consider adding these stocks to their watchlist. All rights reserved. Options expert Jeff Clark is on a mission to show every American at or near retirement how easy it is to trade options. Receive Analysts' Upgrades and Downgrades Daily. Today, the average trading volume of ACST was 5.66M shares. This company achieved a return on equity of -209.21. Get daily stock ideas top-performing Wall Street analysts. During the day, the... As on November 11, 2020, Kinder Morgan Inc. (NYSE: KMI) got off with the flyer as it spiked 1.09% to $13.03. The organization now has a market capitalization sitting at $22.64 million. The stock is currently up by over... Polar Power Inc shot up yesterday to close the day with gains of 58%. In addition, Acasti Pharma Inc. saw -90.46% in overturn over a single year, with a tendency to cut further losses. Acasti Pharma Inc. (NASDAQ:ACST) went up by 23.72% from its latest closing price compared to the recent 1-year high of $3.08. The Nasdaq has dropped 10% over the last three sessions and is now in “correction” territory. View which stocks are hot on social media with MarketBeat's trending stocks report. Save my name, email, and website in this browser for the next time I comment. Hits 7% Following Win over Labor Laws, UBER’s Market Valuation Surpasses an All-time High. B. Riley FBR, on the other hand, stated in their research note that they expect to see ACST reach a price target of $2. The key reasons why General Motors Company (GM) is -2.48% away from 52-week high? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year. Learn everything you need to know about successful options trading with this three-part video course. He’s found 40 1,000% or higher stock market winners. Acasti Pharma Inc.’s current insider ownership accounts for 8.64%, in contrast to 3.12% institutional ownership. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Ever since dropping like a rock in late August, the penny stock hasn't managed to make any lasting move. Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the… Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Looking for new stock ideas? Announces the Initiation of Research Coverage on Acasti Pharma, Inc. During the day,... Witnessing the stock’s movement on the chart, on November 11, 2020, Marathon Oil Corporation (NYSE: MRO) had a quiet start as it plunged 0.00%... You have entered an incorrect email address! The rating they have provided for ACST stocks is “Buy” according to the report published on July 06th, 2020. Press Release reported on 10/01/20 that Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock … Acasti Pharma Inc.’s EPS increase for this current 12-month fiscal period is 30.30% and is forecasted to reach -0.35 in the upcoming year. Want to see which stocks are moving? Most of the world's richest investors totally ignore company fundamentals like P/E ratios. Looking at the stock we see that its previous close was $0.19 and the beta (5Y monthly) reads … And today, he’s revealing the critical top trend to watch and his next potential 1,000% winner for free, right here. Encode Ideas, L.P. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 95.01% that was lower than 200.56% volatility it exhibited in the past 100-days period. Acasti Pharma Inc. (NASDAQ: ACST) established initial surge of 23.72% at $0.23, as the Stock market unbolted on November 10, 2020. Sign up today to receive free access and a guided tour through our program, PATH TO SUCCESS. Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021 feeds.benzinga.com - August 13 at 8:52 AM: Why Acasti Pharma's Stock Is Trading Higher Today finance.yahoo.com - July 6 at 10:38 PM: Why Acasti Pharma's Stock Is Trading Higher Today www.benzinga.com - July 6 at 5:38 PM: Acasti Pharma files for $200M mixed shelf The total capital return value is set at -191.04, while invested capital returns managed to touch -208.56. You have entered an incorrect email address! Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.